Author:
Papachristofilou Alexandros,Souchon Rainer,Claßen Johannes,Krege Susanne,Heinzelbecker Julia
Publisher
Springer Berlin Heidelberg
Reference37 articles.
1. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, Oldenburg J et al (2017) EAU guideline testicular cancer. http://uroweb.org/guideline/testicular-cancer/. Zugegriffen am 13.03.2019
2. Bamberg M, Schmidberger H, Meisner C, Classen J, Souchon R, Weinknecht S, Flink M et al (1999) Radiotherapy for stages I and IIA/B testicular seminoma. Int J Cancer 83(6):823–827. http://www.ncbi.nlm.nih.gov/pubmed/10597202. Zugegriffen am 13.03.2019
3. Belt-Dusebout AW van den, de Wit R, Gietema JA, Horenblas S, Louwman MWJ, Ribot JG, van Leeuwen FE et al (2007) Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 25(28):4370–4378. https://doi.org/10.1200/JCO.2006.10.5296
4. Beyer J, Albers P, Altena R, Aparicio J, Bokemeyer C, Busch J, Wittekind C et al (2013) Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol 24(4):878–888. https://doi.org/10.1093/annonc/mds579
5. Borski AA (1973) Proceedings: diagnosis, staging, and natural history of testicular tumors. Cancer 32(5):1202–1205. http://www.ncbi.nlm.nih.gov/pubmed/4757911. Zugegriffen am 13.03.2019